SMS Pharmaceuticals 配当と自社株買い
配当金 基準チェック /36
SMS Pharmaceuticals配当を支払う会社であり、現在の利回りは0.17%で、収益によって十分にカバーされています。
主要情報
0.2%
配当利回り
n/a
バイバック利回り
| 総株主利回り | n/a |
| 将来の配当利回り | n/a |
| 配当成長 | -4.2% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ₹0.400 |
| 配当性向 | 6% |
最近の配当と自社株買いの更新
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08Recent updates
Risks Still Elevated At These Prices As SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares Dive 25%
Nov 14SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
決済の安定と成長
配当データの取得
安定した配当: SMSPHARMAの1株当たり配当金は過去10年間安定しています。
増加する配当: SMSPHARMAの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| SMS Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (SMSPHARMA) | 0.2% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.2% |
| 業界平均 (Pharmaceuticals) | 0.7% |
| アナリスト予想 (SMSPHARMA) (最長3年) | n/a |
注目すべき配当: SMSPHARMAの配当金 ( 0.17% ) はIndian市場の配当金支払者の下位 25% ( 0.25% ) と比べると目立ったものではありません。
高配当: SMSPHARMAの配当金 ( 0.17% ) はIndian市場の配当金支払者の上位 25% ( 1.17% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: SMSPHARMAの配当性向は低く ( 5.7% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: SMSPHARMAは配当金を支払っていますが、同社にはフリーキャッシュフローがありません。